{
  "pmid": "19933960",
  "uid": "19933960",
  "title": "Bringing the FDA's Information to Market.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Woloshin",
      "fore_name": "Steven",
      "initials": "S",
      "name": "Steven Woloshin",
      "affiliations": [
        "Veterans Affairs Outcomes Group, Veterans Affairs Medical Center, VT 05055, USA."
      ]
    },
    {
      "last_name": "Schwartz",
      "fore_name": "Lisa M",
      "initials": "LM",
      "name": "Lisa M Schwartz",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Archives of internal medicine",
    "iso_abbreviation": "Arch Intern Med",
    "issn": "1538-3679",
    "issn_type": "Electronic",
    "volume": "169",
    "issue": "21",
    "pub_year": "2009",
    "pub_month": "Nov",
    "pub_day": "23"
  },
  "start_page": "1985",
  "end_page": "1987",
  "pages": "1985-7",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Research Support, Non-U.S. Gov't",
    "Comment"
  ],
  "keywords": [
    "Adverse Drug Reaction Reporting Systems",
    "Advertising",
    "Cyclooxygenase 2 Inhibitors",
    "Drug Industry",
    "Drug Labeling",
    "Drug Prescriptions",
    "Humans",
    "Information Dissemination",
    "Lactones",
    "Meta-Analysis as Topic",
    "Myocardial Infarction",
    "Safety-Based Drug Withdrawals",
    "Sulfones",
    "Time Factors",
    "United States",
    "United States Food and Drug Administration"
  ],
  "article_ids": {
    "pubmed": "19933960",
    "doi": "10.1001/archinternmed.2009.399",
    "pii": "169/21/1985"
  },
  "doi": "10.1001/archinternmed.2009.399",
  "dates": {
    "completed": "2009-12-08",
    "revised": "2024-12-19"
  },
  "chemicals": [
    "Cyclooxygenase 2 Inhibitors",
    "Lactones",
    "Sulfones",
    "rofecoxib"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:57:03.427165",
    "pmid": "19933960"
  }
}